Table 7.
Concentration (μmol/mL) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
NC | INU | scFOS | PO | PE | Overall p Value | |||||||
8 h | 24 h | 8 h | 24 h | 8 h | 24 h | 8 h | 24 h | 8 h | 24 h | 8 h | 24 h | |
TSCFAs | 11.67 (11.44–18.27) a | 23.44 (22.94–28.34) a,b |
28.21 (22.80–41.49) a | 47.78 (39.33–66.32) a,b |
31.11 (26.93–47.15) a | 63.78 (46.38–79.41) a,b |
36.74 (30.63–44.75) a | 60.81 (51.83–69.15) a,b |
47.21 (36.06–52.26) *,a |
78.61 (60.99–84.45) *,a,b |
0.007 | 0.005 |
AA | 8.03 (6.45–11.69) a | 14.58 (12.07–17.25) a,b | 17.74 (15.76–31.10) a | 33.82 (23.50–52.40) a,b | 22.96 (18.35–38.53) a | 52.91 (34.03–70.19) *,a,b | 26.35 (19.85–27.67) a | 30.12 (27.82–37.95) a,b | 26.58 (23.52–37.06) *,a | 40.53 (30.59–52.39) a | 0.013 | 0.012 |
PPA | 2.21 (1.74–2.63) a | 3.80 (3.18–4.12) a,b |
4.37 (2.28–4.65) a |
5.80 (3.20–6.22) a,b |
3.51 (2.03–5.24) a |
3.87 (2.39–6.24) a,b |
6.94 (3.64–7.40) a |
9.69 (9.29–12.13) *,a,b |
7.88 (3.33–11.22) *,a |
12.63 (9.79–17.90) *,†,a, b |
0.029 | 0.001 |
BA | 1.80 (1.62–2.56) | 3.34 (2.81–4.91) a,b |
5.04 (3.09–6.68) a |
9.35 (5.61–11.71) a,b |
4.99 (2.19–6.50) a |
6.10 (2.54–9.75) a |
7.39 (3.29–10.28) a |
17.86 (10.18–20.37) *,a,b |
6.99 (2.73–11.61) a |
19.97 (7.35–26.23) *,a,b |
0.042 | 0.010 |
BSCFAs | 0.53 (0.37–1.27) a | 2.25 (2.24–2.30) a,b |
0.22 (0.19–0.34) a |
0.48 (0.43–0.92) a,b |
0.20 (0.15–0.31) *,a |
0.24 (0.18–0.28) * |
0.25 (0.21–0.35) a |
0.59 (0.31–2.32) a,b |
0.29 (0.24–0.63) a |
0.91 (0.29–1.55) a,b |
0.030 | 0.003 |
Other | 0.32 (0.24–0.54) a | 0.84 (0.78–0.94) a,b |
0.23 (0.18–0.32) |
0.28 (0.26–0.45) a,b |
0.17 (0.15–0.27) |
0.19 (0.16–0.29) * |
0.17 (0.15–0.37) |
0.32 (0.24–1.48) b |
0.15 (0.13–0.51) |
0.37 (0.20–1.25) a,b |
0.257 | 0.029 |
Other | 2.72 (1.79–3.52) | 3.41 (3.00–3.89) |
0.71 (0.63–1.04) a |
0.62 (0.41–1.01) a |
0.54 (0.41–0.82) *,a |
0.30 (0.22–0.58) *,a |
0.55 (0.47–0.86) a |
0.53 (0.46–2.22) a |
0.39 (0.32–1.05) *,a |
0.51 (0.34–1.49) a |
0.007 | 0.022 |
Values are expressed as median and Q1–Q3 quartiles for non-parametric data; a: significantly different compared to t = 0 h for ASD children and treatment (Wilcoxon signed-rank test); *: significantly different compared to NC after 24 h of fermentation for ASD children (Kruskall–Wallis test with pairwise comparisons); †: significantly different compared to scFOS after fermentation for ASD children (Kruskall–Wallis test with paiwise comparisons); b: significantly different compared to 8 h of fermentation for each condition and treatment (Wilcoxon signed rank test). AA: acetate, PPA: Propionate, BA: butyrate, BSCFAs: Branched short-chain fatty acids.